Biomerica (BMRA) EBITDA Margin (2010 - 2026)
Biomerica recorded quarterly EBITDA Margin of 132.93% in Q1 2026, down 21.76% quarter-over-quarter from 109.17% in Q4 2025, and down 2891.0% year-over-year from 4.76% in Q1 2025.
Biomerica's EBITDA Margin history runs 17 years deep, the most recent figure standing at 132.93% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 2891.0% year-over-year to 132.93%; the TTM figure through Feb 2026 stood at 96.28% (down 1067.0% YoY), while the FY2025 annual figure was 93.69%, up 1656.0% from the prior year.
- EBITDA Margin came in at 132.93% for Q1 2026 at Biomerica, down from 109.17% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 0.29% in Q3 2025 to a low of 205.07% in Q2 2025.
- A 5-year average of 102.59% and a median of 109.17% in 2025 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin soared 12888 bps in 2022 and plunged 14847 bps in 2023, its largest moves.
- Biomerica's EBITDA Margin stood at 110.32% in 2022, then grew by 13 bps to 96.17% in 2023, then surged by 39 bps to 58.31% in 2024, then tumbled by 87 bps to 109.17% in 2025, then retreated by 22 bps to 132.93% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 132.93%, 109.17%, and 0.29% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 | -132.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -132.93% |
| Nov 30, 2025 | -109.17% |
| Aug 31, 2025 | 0.29% |
| May 31, 2025 | -205.07% |
| Feb 28, 2025 | -104.02% |
| Nov 30, 2024 | -58.31% |
| Aug 31, 2024 | -73.16% |
| May 31, 2024 | -127.33% |
| Feb 29, 2024 | -188.40% |
| Nov 30, 2023 | -96.17% |
| Aug 31, 2023 | -65.73% |
| May 31, 2023 | -161.64% |
| Feb 28, 2023 | -149.86% |
| Nov 30, 2022 | -110.32% |
| Aug 31, 2022 | -127.37% |
| May 31, 2022 | -33.42% |
| Feb 28, 2022 | -1.39% |
| Nov 30, 2021 | -24.32% |
| Aug 31, 2021 | -122.68% |
| May 31, 2021 | -162.30% |
| Feb 28, 2021 | -58.69% |
| Nov 30, 2020 | -125.29% |
| Aug 31, 2020 | -165.57% |
| May 31, 2020 | -30.23% |
| Feb 29, 2020 | -73.23% |
| Nov 30, 2019 | -30.50% |
| Aug 31, 2019 | -42.68% |
| May 31, 2019 | -67.62% |
| Feb 28, 2019 | -53.94% |
| Nov 30, 2018 | -32.10% |
| Aug 31, 2018 | -35.59% |
| May 31, 2018 | -59.41% |
| Feb 28, 2018 | -23.53% |
| Nov 30, 2017 | -16.92% |
| Aug 31, 2017 | -14.39% |
| May 31, 2017 | -23.95% |
| Feb 28, 2017 | -20.29% |
| Nov 30, 2016 | -14.22% |
| Aug 31, 2016 | -3.93% |
| May 31, 2016 | -92.42% |
| Feb 29, 2016 | -9.92% |
| Nov 30, 2015 | -5.82% |
| Aug 31, 2015 | -5.65% |
| May 31, 2015 | 16.25% |
| Feb 28, 2015 | -9.04% |
| Nov 30, 2014 | -21.06% |
| Aug 31, 2014 | -21.29% |
| May 31, 2014 | 10.06% |
| Feb 28, 2014 | 1.70% |
| Nov 30, 2013 | -26.02% |
| Aug 31, 2013 | -16.55% |
| May 31, 2013 | 2.98% |
| Feb 28, 2013 | -2.67% |
| Nov 30, 2012 | 12.55% |
| Aug 31, 2012 | 17.13% |
| May 31, 2012 | 3.51% |
| Feb 29, 2012 | 11.99% |
| Nov 30, 2011 | 11.99% |
| Aug 31, 2011 | 8.34% |
| May 31, 2011 | 7.91% |
| Feb 28, 2011 | 5.43% |
| Nov 30, 2010 | -15.30% |